OR WAIT null SECS
September 09, 2020
The Faciliflex Express product line can be commissioned in six months, making it ideal for cell and gene therapy companies that need to rapidly bring their therapies to patients.
July 07, 2020
The new site will offer initial design and development, low-volume manufacturing, and scalable high-quality production of wearable drug delivery devices.
July 02, 2020
The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.
June 02, 2020
Consider how to assess risks and understand possible sources of disinfectant residues in pharmaceutical manufacturing.
May 15, 2020
A variety of assays should be used to detect bacterial, fungal, and viral contaminants in the human source cells used for cell therapies.
The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.
April 02, 2020
Because conventional cleaning methods can risk product loss, biopharmaceutical manufacturers are often reluctant to use PDE/ADE limits to validate cleaning processes.
February 02, 2020
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.
January 31, 2020
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
January 22, 2020
The fully integrated, pre-qualified, pre-installed aseptic filling facility can be shipped globally for drug development and the manufacturing of personalized medicines and clinical trial supplies.